Savara (SVRA) Change in Acquisitions & Divestments (2018 - 2026)
Savara (SVRA) reported Change in Acquisitions & Divestments of $13.1 million for Q1 2026, down 70.42% year-over-year from $44.4 million in Q1 2025, and down 55.33% on a QoQ basis from $29.4 million in Q4 2025.
Savara (SVRA) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $13.1 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 70.42% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.9 million (down 10.11% YoY) and the FY2025 annual result came in at $182.2 million, up 10.42% from the prior year.
- Change in Acquisitions & Divestments fell to $13.1 million in Q1 2026 per SVRA's latest filing, from $29.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $72.3 million in Q2 2022 and bottomed at -$72.3 million in Q3 2022.
- The 5-year median for Change in Acquisitions & Divestments is $39.3 million (2023), against an average of $31.8 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 333.04% in 2022, while the deepest fall reached 309.07% in 2022.
- Tracing SVRA's Change in Acquisitions & Divestments over 5 years: stood at -$72.3 million in 2022, then soared by 162.78% to $45.4 million in 2023, then advanced by 10.02% to $49.9 million in 2024, then slumped by 41.14% to $29.4 million in 2025, then plunged by 55.33% to $13.1 million in 2026.
- Per Business Quant, the three latest SVRA Change in Acquisitions & Divestments figures stand at $13.1 million (Q1 2026), $29.4 million (Q4 2025), and $44.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.13 Mn |
| Mar 31, 2026 | 13.13 Mn |
| Dec 31, 2025 | 29.40 Mn |
| Dec 31, 2025 | 29.40 Mn |
| Sep 30, 2025 | 44.40 Mn |
| Sep 30, 2025 | 44.40 Mn |
| Jun 30, 2025 | 64.00 Mn |
| Jun 30, 2025 | 64.00 Mn |
| Mar 31, 2025 | 44.40 Mn |
| Mar 31, 2025 | 44.40 Mn |
| Dec 31, 2024 | 49.95 Mn |
| Dec 31, 2024 | 49.95 Mn |
| Sep 30, 2024 | 40.55 Mn |
| Sep 30, 2024 | 40.55 Mn |
| Jun 30, 2024 | 33.00 Mn |
| Jun 30, 2024 | 33.00 Mn |
| Mar 31, 2024 | 41.50 Mn |
| Mar 31, 2024 | 41.50 Mn |
| Dec 31, 2023 | 45.40 Mn |
| Dec 31, 2023 | 45.40 Mn |
| Sep 30, 2023 | 38.00 Mn |
| Sep 30, 2023 | 38.00 Mn |
| Jun 30, 2023 | 30.00 Mn |
| Jun 30, 2023 | 30.00 Mn |
| Mar 31, 2023 | 24.00 Mn |
| Mar 31, 2023 | 24.00 Mn |
| Sep 30, 2022 | -72.32 Mn |
| Sep 30, 2022 | -72.32 Mn |
| Jun 30, 2022 | 72.32 Mn |
| Jun 30, 2022 | 72.32 Mn |
| Mar 31, 2022 | 11.28 Mn |
| Mar 31, 2022 | 11.28 Mn |
| Dec 31, 2021 | -59.67 Mn |
| Dec 31, 2021 | -59.67 Mn |
| Sep 30, 2021 | 34.59 Mn |
| Sep 30, 2021 | 34.59 Mn |
| Jun 30, 2021 | 16.70 Mn |
| Jun 30, 2021 | 16.70 Mn |
| Mar 31, 2021 | 16.58 Mn |
| Mar 31, 2021 | 16.58 Mn |
| Dec 31, 2020 | 15.55 Mn |
| Dec 31, 2020 | 15.55 Mn |
| Sep 30, 2020 | 65.32 Mn |
| Sep 30, 2020 | 65.32 Mn |
| Jun 30, 2020 | -22.52 Mn |
| Jun 30, 2020 | -22.52 Mn |
| Mar 31, 2020 | 31.30 Mn |
| Mar 31, 2020 | 31.30 Mn |
| Dec 31, 2019 | 35.50 Mn |
| Dec 31, 2019 | 35.50 Mn |
| Sep 30, 2019 | 18.60 Mn |
| Sep 30, 2019 | 18.60 Mn |
| Jun 30, 2019 | 27.80 Mn |
| Jun 30, 2019 | 27.80 Mn |
| Mar 31, 2019 | 42.80 Mn |
| Mar 31, 2019 | 42.80 Mn |
| Dec 31, 2018 | -54.08 Mn |
| Dec 31, 2018 | -54.08 Mn |
| Sep 30, 2018 | 24.85 Mn |
| Sep 30, 2018 | 24.85 Mn |
| Jun 30, 2018 | 14.20 Mn |
| Jun 30, 2018 | 14.20 Mn |
| Mar 31, 2018 | 25.30 Mn |
| Mar 31, 2018 | 25.30 Mn |